Clinical Trial Update: A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu With Rabeprazole Improving Functional Dyspepsia ) (Study E3810-J081-204) [Phase 2]

View source ↗

Summary

Phase 2 study in Japanese subjects with Functional Dyspepsia evaluating E3810 with rabeprazole for acid suppression; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• E3810
• Rabeprazole (rabeprazole)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Functional Dyspepsia | Phase 2 | Status: COMPLETED | Results posted: 2013-11-19